Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lili Sheibani

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Opinion on Pharmacotherapy|July 8, 2015
Pharmacotherapy options for labor inductionDeborah A Wing, Lili Sheibani
Expert Opinion on Drug Safety|November 17, 2017
A safety review of medications used for labour inductionLili Sheibani, Deborah A Wing
Obstetrics and Gynecology Clinics of North America|August 6, 2010
Cholestasis of pregnancyBhuvan Pathak, Lili Sheibani, Richard H Lee
Hypertension in Pregnancy|January 2, 2018
Associations of hypertensive disorders of pregnancy and outcomes of labor induction with prostaglandin vaginal insertsLili Sheibani, Kyle Raymond, Olof Rugarn, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2017
Pregnancy Augments VEGF-Stimulated In Vitro Angiogenesis and Vasodilator (NO and H2S) Production in Human Uterine Artery Endothelial CellsHong-Hai Zhang, Jennifer C Chen, Lili Sheibani, et al.
Biology of Reproduction|March 25, 2017
Augmented H2S production via cystathionine-beta-synthase upregulation plays a role in pregnancy-associated uterine vasodilationLili Sheibani, Thomas J Lechuga, Honghai Zhang, et al.
Endocrinology|April 1, 2015
Estrogen Replacement Therapy in Ovariectomized Nonpregnant Ewes Stimulates Uterine Artery Hydrogen Sulfide Biosynthesis by Selectively Up-Regulating Cystathionine β-Synthase ExpressionThomas J Lechuga, Hong-hai Zhang, Lili Sheibani, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 1, 2016
Maternal and neonatal outcomes after antenatal corticosteroid administration for PPROM at 32 to 33 6/7 weeks gestational age<sup></sup>Lili Sheibani, Alex Fong, Dana E Henry, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|July 8, 2015
Pharmacotherapy options for labor inductionDeborah A Wing, Lili Sheibani
Expert Opinion on Drug Safety|November 17, 2017
A safety review of medications used for labour inductionLili Sheibani, Deborah A Wing
Obstetrics and Gynecology Clinics of North America|August 6, 2010
Cholestasis of pregnancyBhuvan Pathak, Lili Sheibani, Richard H Lee
Hypertension in Pregnancy|January 2, 2018
Associations of hypertensive disorders of pregnancy and outcomes of labor induction with prostaglandin vaginal insertsLili Sheibani, Kyle Raymond, Olof Rugarn, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2017
Pregnancy Augments VEGF-Stimulated In Vitro Angiogenesis and Vasodilator (NO and H2S) Production in Human Uterine Artery Endothelial CellsHong-Hai Zhang, Jennifer C Chen, Lili Sheibani, et al.
Biology of Reproduction|March 25, 2017
Augmented H2S production via cystathionine-beta-synthase upregulation plays a role in pregnancy-associated uterine vasodilationLili Sheibani, Thomas J Lechuga, Honghai Zhang, et al.
Endocrinology|April 1, 2015
Estrogen Replacement Therapy in Ovariectomized Nonpregnant Ewes Stimulates Uterine Artery Hydrogen Sulfide Biosynthesis by Selectively Up-Regulating Cystathionine β-Synthase ExpressionThomas J Lechuga, Hong-hai Zhang, Lili Sheibani, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|September 1, 2016
Maternal and neonatal outcomes after antenatal corticosteroid administration for PPROM at 32 to 33 6/7 weeks gestational age<sup></sup>Lili Sheibani, Alex Fong, Dana E Henry, et al.
Pageof 1